People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pyxis Oncology, Inc. | — | Pharma | Series D+ | $194.5M | $5.0B | 2021 |
Lara Sullivan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lara Sullivan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Steinberg | 1 | 14 |
| Christoph Westphal | 1 | 8 |
| Christopher O'Donnell | 1 | 8 |
| Robert Crane | 1 | 7 |
| Geeta Vemuri | 1 | 7 |
| Lucio Iannone | 1 | 6 |
| Jak Knowles | 1 | 4 |
| John Flavin | 1 | 4 |
| Christian Schetter | 1 | 2 |
| Gotham Makker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.